Key takeaways

  • PMS is common and mild-to-moderate (70–90% of women); PMDD is severe and affects roughly 3–8% of women of reproductive age.
  • PMDD is a recognised psychiatric diagnosis with specific DSM-5 criteria — at least 5 luteal-phase symptoms, one from the core mood cluster, confirmed by tracking across 2 cycles.
  • The hallmark is timing: symptoms appear in the week before your period and lift within a few days of bleeding. A symptom-free week after the period is the key clue.
  • PMDD usually needs medication. SSRIs are first-line and often work within days, not weeks; drospirenone-based pills are an option for many.
  • Suicidal thoughts in the luteal phase are a medical emergency even if they reliably pass — call a helpline and seek care the same week.
  • Prospective daily tracking for two cycles is the single most useful thing you can bring to your first appointment.

The core difference: severity, impact, and DSM-5 criteria

PMS and PMDD share the same underlying biology — cyclical symptoms in the luteal phase (the second half of the cycle) that resolve once your period arrives. What separates them is severity and impact.

PMS affects 70–90% of women of reproductive age. Symptoms are mild to moderate — bloating, breast tenderness, irritability, low energy — and most women manage them with lifestyle changes, supplements and over-the-counter measures. If your low moods come and go without derailing your life, that's usually normal cyclical mood change, not PMDD.

PMDD is different in kind, not just degree. It affects about 3–8% of women, with severe psychiatric and physical symptoms that meet formal diagnostic criteria, and it almost always needs medication for adequate control. In the late luteal phase the impact can rival a major depressive episode.

DSM-5 criteria for PMDD, in plain terms. In most cycles over the past year, at least 5 symptoms must be present in the final week before the period, improve within a few days of bleeding starting, and become minimal or absent in the week after. At least one must be from the core mood cluster:

  • marked mood swings or sudden tearfulness
  • marked irritability, anger or increased conflict
  • marked depressed mood, hopelessness or self-critical thoughts
  • marked anxiety, tension or feeling “on edge”

Additional symptoms (to reach 5 total) include reduced interest in usual activities, difficulty concentrating, fatigue, appetite or sleep changes, feeling overwhelmed or out of control, and physical symptoms such as breast tenderness, joint or muscle pain, and bloating. Crucially, the symptoms must cause real distress or interfere with work, relationships or daily function — and must be confirmed by prospective daily tracking over at least two cycles before the diagnosis is made.

Track it for two cycles — the step most women skip

Here is the single most important thing to know about getting a PMDD diagnosis: it cannot be made from memory. Trying to recall how you felt three weeks ago while sitting in a crowded OPD is unreliable — doctors call this recall bias. The DSM-5 and Indian gynaecologists alike require prospective daily tracking before confirming PMDD, because only a real-time record can prove the symptoms are truly cyclical.

The gold-standard tool is the Daily Record of Severity of Problems (DRSP). You rate a fixed list of symptoms — irritability, hopelessness, anxiety, bloating and others — each day on a simple severity scale. After two cycles, a clear pattern usually emerges: a calm, symptom-free week after the period, a steady build through the mid-luteal phase, and a sharp drop within 2–3 days of bleeding starting.

Why this matters so much: if your distress runs all month and only worsens before your period, that points to premenstrual exacerbation of an underlying condition rather than true PMDD — and the treatment is different. A genuinely symptom-free follicular week (the days after your period) is the deciding clue.

How to track in real life. Use whatever you'll actually keep up with:

  • A free paper DRSP chart or a simple notebook — a discreet option if phone privacy is a concern in a shared household.
  • A cycle app. SHELY's own mood journal method is built around this kind of daily logging, and apps designed for neurodivergent users use visual, low-effort formats.
  • Set a daily alarm and log twice — morning (baseline mood on waking) and evening (the day's intensity).

Be honest about the hard symptoms — rage, withdrawal, intrusive thoughts — which are often hidden out of habit or shame. Two cycles of data is your strongest asset: it shifts the consultation from “I think it's my hormones” to clear evidence, and it shields you from a too-quick “it's just stress” dismissal. It also helps at home — showing a partner or parent a graph of the monthly peaks and troughs can turn a recurring conflict into a shared medical problem.

What looks like PMDD but isn't

Several conditions mimic PMDD, and ruling them out protects you from the wrong treatment. This is why tracking and a few basic tests come first.

Premenstrual exacerbation (PME) of another condition. In PME, symptoms of an existing disorder — depression or anxiety, for example — are present all month but flare in the luteal phase. True PMDD requires a symptom-free follicular week. Missing this distinction can leave an underlying depression undertreated.

Common medical mimics that deserve a quick screen:

  • Thyroid disorders. Hypothyroidism is common in Indian women and causes fatigue, brain fog and low mood that overlap with premenstrual distress. A simple TSH test settles it.
  • Anaemia and iron deficiency. More than half of Indian women are anaemic. Iron deficiency causes cyclical exhaustion and irritability — a haemoglobin and ferritin check is worth doing.
  • Vitamin deficiencies. Vitamin D and B12 deficiencies are very common, especially in vegetarian diets, and can drive low mood and fatigue.
  • Perimenopause. In women over 40, fluctuating oestrogen can produce PMDD-like mood swings, hot flushes and disrupted sleep.

Psychiatric differentials. Bipolar disorder involves periods of elevated energy, racing thoughts or impulsivity (hypomania) that PMDD does not. Generalised anxiety or panic disorder worsen premenstrually but persist into the first week of the period. Many women with ADHD or autism find their usual coping collapses in the premenstrual week — real, but a different picture from isolated PMDD.

The “social differential.” Chronic stress — workplace pressure, financial strain, difficult home dynamics — can produce cyclical emotional outbursts that look like PMDD. A useful self-check: if your symptoms ease noticeably on weekends or holidays, external stress is likely a major factor. Alcohol is a depressant that deepens the luteal-phase low and disrupts sleep, so it can muddy the picture too.

In India, where care is often paid out of pocket, starting with low-cost screening (TSH, a complete blood count and ferritin) at a government PHC or local clinic rules out the most common physical causes before moving to specialist psychiatric evaluation. Whatever the origin, your distress is real — and the path to relief starts with a diagnostic process that includes two cycles of tracking.

Why PMDD happens: the biology

One of the most frustrating things about PMDD is that hormone blood tests almost always come back normal — which is exactly why it gets dismissed as “all in your head.” But normal hormones are the whole point. PMDD is not a hormone imbalance; it is an abnormal brain sensitivity to normal hormonal change.

Here's what current research describes. The progesterone metabolite allopregnanolone normally has a calming effect by acting on GABA-A receptors in the brain. In women with PMDD, this same metabolite seems to trigger a paradoxical response — instead of feeling settled in the luteal phase, the brain's emotional circuits move into a state of alarm, anxiety and irritability. Serotonin signalling also appears to dip in the luteal phase in those affected, which is why serotonin-targeting medicines work so well.

There's a genetic thread too: PMDD often runs in families, and research points to differences in how cells respond to oestrogen and progesterone. This matters in the Indian context, where a mother or grandmother who “suffered in silence” may have had the same inherited vulnerability — not a “bad temper.” Understanding PMDD as a neurochemical sensitivity, similar to how hormones and mood are wired together across the cycle, helps dismantle the shame that keeps so many women from seeking help.

This biology also explains the treatment logic. Because the trigger is the brain's reaction to ovulatory hormone shifts, two strategies work: re-tune the brain's sensitivity (SSRIs), or remove the trigger by suppressing ovulation (hormonal options). It is a measurable, targetable condition — not a personality flaw.

SSRIs: first-line treatment

Selective serotonin reuptake inhibitors (SSRIs) are the first-line medical treatment for PMDD, and they behave very differently here than they do for depression. For PMDD, relief often comes within days rather than the 4–6 weeks typical in depression — a fast response that is itself a useful diagnostic clue. Most women who respond describe it as getting themselves back. SSRIs commonly used in India include fluoxetine, sertraline, escitalopram and paroxetine; all are widely available and inexpensive, and generic versions are stocked at Jan Aushadhi Kendras.

What's unique to PMDD is the flexibility in how you take them:

  • Continuous dosing — every day, all month. The most reliable approach with the strongest evidence.
  • Luteal-phase dosing — starting about 14 days before the period and stopping when bleeding begins. This reduces total exposure and roughly halves the monthly cost.
  • Symptom-onset dosing — taking it at the first sign of symptoms each cycle. This needs accurate cycle tracking to time well.

Managing side effects. Early on, mild nausea, sleep changes or vivid dreams are common and usually settle within 1–2 weeks. Taking the dose with food (a breakfast of poha or paratha) eases nausea, and a morning dose helps if sleep is affected. Reduced libido or delayed orgasm can persist for some; this is manageable by switching SSRIs or adjusting the dose under medical supervision — never stop abruptly on your own. These are real effects, but they are not a personality change.

For adolescents and young adults, close monitoring in the first few weeks is recommended to watch for any increase in agitation or low mood. The dose and choice of SSRI should always be individualised with a doctor.

Hormonal options: drospirenone pills and beyond

If SSRIs aren't enough — or if you also want reliable contraception — hormonal treatment targets PMDD at the source by suppressing ovulation, so the brain is never exposed to the hormonal swings that set off symptoms.

Drospirenone-based combined oral contraceptives (COCs) have the best evidence among hormonal options and are available in India under several brands. Because the placebo (sugar-pill) week can cause a rebound of symptoms, many doctors recommend a continuous regimen — skipping the placebo week and starting the next pack — to keep hormones steady. Skipping periods this way is medically safe, though breakthrough spotting is common in the first few months as the body adjusts. If you're weighing this up, our guides to birth control pills in India and what side effects are normal versus worth acting on are useful companions. It can help, socially, to think of these as ovulation-stabilising treatment for a medical condition rather than only “the pill.”

GnRH agonists are reserved for refractory PMDD that hasn't responded to SSRIs and COCs. Given as injections, they switch the ovaries off entirely, inducing a temporary, reversible “medical menopause.” Because this can affect bone density and cause hot flushes, specialists add add-back therapy (a low dose of oestrogen and progestogen) to protect bones and the heart, and use is usually limited to 6–12 months. It also doubles as a diagnostic test: if symptoms vanish, it confirms the ovaries are the trigger.

Surgery (removal of both ovaries) is the definitive option but a last resort — considered only for women who have completed their families, have severe treatment-resistant PMDD, and have already shown a clear benefit from a GnRH-agonist trial. It commits a woman to hormone therapy until the natural age of menopause and is a path very rarely taken.

Across all of these, bring two cycles of tracking to your appointment and seek a gynaecologist comfortable with PMDD specifically — ideally one who works alongside a psychiatrist.

CBT, therapy and behavioural approaches

Cognitive behavioural therapy (CBT) is a well-supported non-medication treatment for PMDD, and for some women it works as well as an SSRI — particularly for the relationship strain and self-esteem hits that the condition causes. CBT doesn't pretend the biology isn't there; it targets the story the luteal phase tells you. The physical wave of anxiety is hormonally driven, but the narrative of “I'm a failure” or “no one could love me” is something therapy can catch and challenge.

A practical, India-aware version of this includes:

  • Cycle-aware pacing. Schedule demanding tasks and big social commitments for the follicular phase; protect the luteal week.
  • A communication plan. Agreed-in-advance “I” statements (“I'm feeling overwhelmed and need 30 minutes of quiet”) replace reactive conflict. Families and partners can learn to respect the need for space during this week.
  • Reframing. Understanding PMDD as a documented medical sensitivity, like managing diabetes, reduces the shame that therapy still carries for many.

Where to find care in India. Public institutions like NIMHANS, AIIMS and PGI Chandigarh offer expert psychological care at very low fees, though waits can be long. Private hospital mental-health wings and Indian tele-therapy platforms have widened access, including for women in smaller cities who value the privacy of an online session. Under the Mental Healthcare Act 2017, insurers are required to cover mental-health treatment on par with physical health — worth asserting when you claim.

Couples and family therapy can be especially powerful. When PMDD shows up as intense interpersonal sensitivity, partners can end up “walking on eggshells.” Reframing it as a shared, predictable biological challenge — with agreed warning signs and a calm response plan — takes the blame out and reduces the monthly damage-control cycle.

Lifestyle, supplements and self-care

Lifestyle measures rarely cure PMDD on their own, but they are the scaffolding that makes medical treatment work better and lowers the baseline stress that fuels severe luteal flares.

Diet and movement.

  • Favour complex carbohydrates — ragi, jowar, oats — over refined rice and maida to avoid blood-sugar swings that worsen luteal mood.
  • Anchor meals with protein (sprouts, paneer, dal) to stay full and steady.
  • Aim for about 150 minutes of aerobic activity a week — brisk walking, dance, gentle cycle-friendly movement. Movement helps regulate serotonin and is one of the most reliable mood levers.
  • Protect sleep: a consistent wind-down and less late-night screen time genuinely affects premenstrual mood.

Supplements with reasonable evidence (give them 2–3 cycles):
  • Calcium (around 1,000–1,200 mg/day) has the strongest supporting evidence for premenstrual symptoms.
  • Vitamin B6 at modest doses supports serotonin synthesis — stay within recommended limits, as very high doses can harm nerves.
  • Magnesium may help bloating and “brain fog” for some.
  • Vitamin D, if you're deficient (very common in India), is worth correcting after a blood test.

Stress, calm and triggers. Pranayama and yoga help lower stress in the late luteal phase, and a deliberate digital detox before your period can protect your focus and mood. Alcohol is a potent trigger for loss-of-control feelings — best avoided in the late luteal week — and heavy chai or coffee can amplify anxiety and palpitations. Chasteberry (Vitex agnus-castus) helps some women with milder physical symptoms but should not be combined with hormonal contraceptives without medical advice.

Seeing these monthly waves as part of a wider pattern — the way hormones drive emotional tides across the cycle — can make them feel less random and more manageable. For moderate-to-severe PMDD, though, these measures support but do not replace SSRIs or hormonal treatment.

Suicidal thoughts in PMDD: an urgent concern

This deserves its own section because PMDD carries a genuinely raised risk of suicidal thinking. A large share of women with PMDD report suicidal thoughts during the luteal phase, and a smaller but significant share report attempts. In India these numbers are often hidden behind the silence expected around menstruation.

The most important message: do not wait it out. Even when the dark thoughts reliably lift the moment your period starts, they are a true emergency in the moment. The predictable timing is actually useful — it lets you plan ahead.

If you are in crisis now, reach out immediately. These are free and confidential:

  • Tele MANAS (national mental health helpline): 14416 or 1800-891-4416
  • KIRAN mental health helpline: 1800-599-0019 (24/7, multiple languages)
  • iCall: 9152987821
  • Vandrevala Foundation: 1860-2662-345
  • AASRA: 9820466726

Go to a hospital emergency department if you feel unsafe — emergency teams are equipped to stabilise acute mental-health crises.

Build a luteal safety plan for the high-risk days each cycle:
  • Name a “safe person” (partner, sister, friend) and tell them in advance: “The hormones are driving these thoughts and I need extra support this week.”
  • Remove access to means of harm during the 7–10 high-risk days, the same way you'd take sensible precautions during any temporary medical crisis.
  • Have your psychiatrist's or helpline number saved and visible.

And hold onto this: PMDD-related suicidal thinking responds well to SSRIs and to ovulation suppression. The luteal phase can feel like an endless tunnel, but it is biologically transient and medically treatable. The risk is real — and so is the recovery.

The India pathway: gynaecology, psychiatry and putting it together

PMDD is ideally managed by a gynaecologist and a psychiatrist working together, though in practice the pathway is variable. A realistic route looks like this:

  1. See a gynaecologist first for a baseline workup — TSH, haemoglobin, ferritin, vitamin D, fasting glucose and a pelvic ultrasound to rule out medical mimics — and to start initial treatment (an SSRI and/or a COC).
  2. Add psychiatry if symptoms are severe, with significant mood, anxiety, suicidal thoughts or relationship impact. You can ask for a referral or approach a psychiatrist directly.
  3. Bring two cycles of tracking to every appointment. Many doctors are more familiar with general PMS than PMDD specifically, and your data closes that gap.

Access options: in-person consultations at major hospitals; tele-psychiatry platforms that have transformed access for women in tier-2 and tier-3 cities; government mental-health centres and district hospital psychiatry OPDs at minimal cost; and NIMHANS Bangalore as the national reference centre for complex cases. Most Indian health insurance now covers psychiatric care under the Mental Healthcare Act 2017 — check your policy specifics.

The investment in a proper diagnosis usually pays back many times over in restored relationships, steadier work and a life that no longer runs on a monthly cliff-edge.

PMDD myths, corrected

Myth: PMDD is just severe PMS — same condition, different label

  • False. PMDD is a distinct DSM-5 diagnosis with specific criteria — at least 5 luteal-phase symptoms including one core mood symptom, confirmed by prospective tracking across two cycles, with real functional impairment. It is not simply bad PMS.
  • The treatment differs too. PMDD nearly always needs medication (SSRIs first-line, drospirenone-based COCs as an option), while most PMS responds to lifestyle, nutrition and supplements. Treating PMDD as if it were PMS leads to undertreatment; the right diagnosis matters, and tracking is how you get it.

Myth: PMDD isn't real — it's just bad behaviour blamed on hormones

  • False. PMDD has been a recognised DSM-5 diagnosis since 2013 and is included in the ICD-11 as a gynaecological condition. The biology — an abnormal brain sensitivity to normal cyclical hormone change, with neuroactive-steroid and serotonin involvement — is increasingly well understood.
  • Dismissing PMDD as drama or attention-seeking does real harm to women whose suffering is genuine and treatable. The right response is medical evaluation, treatment and support — not blame.

Myth: SSRIs change your personality — you won't be yourself anymore

  • False. SSRIs at PMDD doses don't change your underlying personality; they reduce the neurochemical over-reaction to hormonal change. Most women describe feeling more like their usual self across the whole cycle, not less.
  • Side effects (sexual effects, early sleep changes, initial nausea, occasional mild emotional blunting) are real but different from personality change, and can be managed by dose adjustment, switching SSRIs or supervised breaks. Raise any concern with the prescribing doctor.

Myth: PMDD only affects women in their 30s and disappears at menopause

  • Partly true, partly misleading. PMDD can begin any time from the first period onward; adolescent PMDD is well documented. It typically continues until menopause stops ovulation, and some women find it worsens in the perimenopausal years first.
  • Waiting for menopause can mean 10–30 years of severe cyclical symptoms in the meantime. Active treatment in the reproductive years is the right approach, and perimenopausal women benefit from management too — sometimes shifting to include menopausal hormone therapy considerations.

Frequently asked questions

How do I know if I have PMDD and not just bad PMS?

The deciding factor is severity, impact and timing. PMDD brings at least 5 severe luteal-phase symptoms — including marked mood swings, irritability, depression or anxiety — that disrupt your work or relationships, then lift within a few days of your period starting, leaving a symptom-free week afterward. The only way to confirm it is prospective daily tracking across two cycles, ideally with a DRSP chart or a cycle app.

Will I have to take medication forever?

Not necessarily. Many women use luteal-phase-only SSRI dosing (about 14 days each cycle) rather than continuous treatment, and some manage with a drospirenone-based pill, CBT and lifestyle measures. Treatment is highly individual and can be reviewed and adjusted with your doctor over time.

Do SSRIs really work that fast for PMDD?

Yes — unlike in depression, where they take 4–6 weeks, SSRIs often ease PMDD symptoms within days. This is because in PMDD they appear to act quickly on the brain's response to progesterone metabolites, not just on long-term mood regulation. The fast response is also a useful clue that the diagnosis is correct.

Can lifestyle changes alone treat PMDD?

For moderate-to-severe PMDD, no — lifestyle measures support treatment but don't replace it. Regular exercise, steady blood sugar, good sleep, calcium and stress reduction lower the baseline and make medication work better. If your symptoms are milder and manageable, you may be dealing with PMS rather than PMDD.

I get suicidal thoughts before my period. Is that PMDD?

Cyclical suicidal thinking that arrives in the luteal phase and resolves with your period is a recognised and serious feature of PMDD. Treat it as an emergency in the moment even though it passes — call Tele MANAS (14416) or KIRAN (1800-599-0019), tell a trusted person, and seek same-week care. PMDD-related suicidality responds well to treatment.

Where do I start in India — a gynaecologist or a psychiatrist?

Usually a gynaecologist first, for a baseline workup (TSH, haemoglobin, ferritin, vitamin D, ultrasound) to rule out mimics and to start an SSRI or pill. Add a psychiatrist if symptoms are severe or involve suicidal thoughts. Tele-psychiatry has made specialist access much easier in smaller cities, and NIMHANS is the national reference centre for complex cases.

Sources